Myriad Genetics (MYGN) Non-cash Items (2010 - 2020)

Myriad Genetics has disclosed Non-cash Items across 11 years of filings, most recently posting $4.8 million for Q2 2020.

• In Q2 2020, Non-cash Items changed N/A year-over-year to $4.8 million; the TTM figure through Jun 2020 stood at $4.8 million (changed N/A YoY), while the FY2020 annual figure was $4.8 million, changed N/A from the prior year.
• Non-cash Items held at $4.8 million in Q2 2020, from $4.8 million in the prior quarter.
• Over the last five years, Non-cash Items for MYGN reached as high as $8.6 million in Q1 2016 and fell as low as $2.2 million in Q1 2017.
• The 5-year median for Non-cash Items is $6.5 million (2016), against an average of $6.1 million.
• Annual changes were most pronounced in 2017 — Non-cash Items slumped 74.42% — and 2018, when it surged 218.18%.
• A 5-year view of Non-cash Items shows it stood at $7.6 million in 2016, then declined by 2.63% to $7.4 million in 2017, then fell by 14.86% to $6.3 million in 2018, then retreated by 22.22% to $4.9 million in 2019, then declined by 2.04% to $4.8 million in 2020.
• According to Business Quant data, Non-cash Items over the past three periods registered $4.8 million, $4.8 million, and $4.9 million for Q2 2020, Q1 2020, and Q4 2019 respectively.